Should I buy Taylor Morrison (TMHC) stock or is it too late?

Taylor Morrison · Consumer Discretionary · price $72

See the full Taylor Morrison (TMHC) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: RBC Capital — 57% of its targets hit on this sector (176 calls tested). It aims for $72.50 (+0.1 %), call made on June 3, 2026, maturing on June 3, 2027 (86 d ago).

The 1 reliable analyst $72.50+0.1 %

The 4 other firms $70.25-3.0 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $72.50 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Taylor Morrison

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	Calls	Aims for
JP Morgan	8	$82 +13%
Barclays	6	$73 +1%
Wedbush	5	$85 +17%
RBC Capital	8	$73 +0%
B. Riley Securities	5	$36 -50%
Credit Suisse	7	—
Citigroup	6	—
Deutsche Bank	6	—

In short — Should you invest in Taylor Morrison? Is it too late, still worth it? Analysts are split (0% buy, median target $73, i.e. +0%), and the most reliable on TMHC targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on TMHC, Barclays (0% hit rate, 6 scored calls), targets $73 (call made on July 14, 2026, maturing on July 14, 2027) (+1%) in its most recent call, and $70 (call made on February 12, 2026, maturing on February 12, 2027) (-3%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 7 are neutral and 1 is a sell.
Limited upside: the median target is only +0% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on TMHC

Median target $73 (+0%) · 8 ratings · Hold consensus

Strong Buy00%

Buy00%

Hold788%

Sell113%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Taylor Morrison now?

We won't decide for you. The facts: 0% of analysts rate it a buy, median target $73 (+0%), and Barclays (most reliable on TMHC, 0%) targets $73. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Taylor Morrison?

The stated upside is small: the median target ($73) sits just +0% from the price ($72) (most reliable on TMHC: Barclays, 0%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Taylor Morrison still worth investing in?

It depends on the gap between the price ($72) and its estimated value: analysts target $73 on median (+0%), with 0% buys (most reliable on TMHC: Barclays, 0%). Cross-check with their real reliability on TMHC and the cautions above. Information, not advice.

What's the main risk in buying TMHC?

The consensus is not unanimous: of 8 ratings, 7 are neutral and 1 is a sell.

→ Go deeper: the full Taylor Morrison profile (consensus, analyst reliability, price target, performance).